Inhibikase Therapeutics, Inc. - Common Stock (IKT)

2.0550
+0.0650 (3.27%)
NASDAQ · Last Trade: May 8th, 11:45 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors